Neogenix awarded Emerging Company of the Year by TCM

Editorial Checklist Reviewed
Neogenix Oncology, Inc.May 15 2010NewsGuard 100/100 Score

Neogenix Oncology, Inc. (Neogenix), announced today that they were awarded "Emerging Company of the Year" by The Tech Council of Maryland (TCM), the state's largest technology trade association at its 22nd Annual Tech Awards including more than 800 technology and business leaders from around the region.

“We are honored and proud to accept the 'Emerging Company of the Year' award and I want to congratulate everyone at Neogenix who made this possible. We are looking forward to growing successfully in the future”

"We are honored and proud to accept the 'Emerging Company of the Year' award and I want to congratulate everyone at Neogenix who made this possible. We are looking forward to growing successfully in the future," said Dr. Philip Arlen, CEO of Neogenix Oncology.

Source:

Neogenix Oncology, Inc.

Posted in:

Tags: , , ,

Comments (0)

Suggested Reading

​MGI Tech shares new data on core DNEBSEQ technology and showcases latest sequencing innovations at ESHG 2024
Advances and hurdles: The impact of AI on oncology care efficiency and mortality rates
Closing the Cancer Care Gap with the Power of Precision Oncology
Breaking through new research barriers with iPSC technology
Foam technology revolutionizes gene therapy, boosting efficiency and safety
Sleep apnea prevalent among cardio-oncology patients, study shows
AI chatbot offers accurate answers to radiation oncology queries
Study evaluates large language models for autocontouring in head and neck radiotherapy

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
AI outperforms peers in medical oncology quiz, yet some mistakes could be harmful